Bank Makramah Limited has informed the market that the expression of interest submitted in June by a DM Holdings-led consortium is “no longer being pursued.”
The bank’s latest communication also refers investors back to an August board decision under which its existing sponsor, Nasser Abdulla Hussain Lootah, may inject a further Rs10 billion, subject to corporate and regulatory approvals.
While the announcement is straightforward, it leaves several important questions unanswered about the consortium proposal, the bank’s capital position and its future ownership structure.
A Three-Month Courtship Ends Without a Reason
On June 11, 2026, Bank Makramah disclosed that the consortium had expressed a firm intention to acquire a significant stake in the bank. Such a transaction could have triggered takeover requirements and potentially resulted in a public offer.
The consortium was led by DM Holdings, a newly established Karachi-based vehicle, and had reportedly indicated a willingness to commit substantial capital to the bank.
Around three months later, Bank Makramah has confirmed that the proposal is no longer being pursued. However, its latest communication does not explain why the discussions ended.
There is no indication of whether the decision followed a valuation disagreement, due-diligence concerns, regulatory considerations or unsuccessful negotiations.
For investors, that absence of detail is significant. Markets can assess a rejected transaction when the terms and reasons are known, but an unexplained withdrawal leaves considerable uncertainty.
Sponsor’s Rs10 Billion Plan Keeps Ownership Structure Intact
The bank’s board approved Nasser Abdulla Hussain Lootah’s proposed Rs10 billion capital injection on August 18.
Under the proposed structure, the funds would initially be received as an advance against share subscription and subsequently converted into shares through an issuance other than a rights issue, subject to the necessary approvals.
The structure would allow the existing sponsor to strengthen the bank’s capital without fundamentally changing its ownership arrangement.
Lootah has remained the dominant shareholder since acquiring an interest in the former Summit Bank in April 2023.
By contrast, a consortium transaction could have brought a new major shareholder into the bank and raised questions around regulatory fitness and propriety, takeover requirements, public-offer mechanics and future control of the institution.
The sponsor-led plan is therefore simpler from an ownership perspective. However, it also means existing shareholders could face further dilution depending on the final terms of the share issuance.
Stronger Capital Does Not Automatically Mean a Turnaround
Bank Makramah has spent the past several years working through significant financial and operational challenges.
The bank underwent a court-backed merger with Global Haly Development Limited and has also pursued recoveries from legacy non-performing loans while receiving additional sponsor support.
These measures have helped the bank bring its minimum capital and capital-adequacy position back above regulatory thresholds.
However, the underlying business remains under pressure.
At the end of 2025, total capital to risk-weighted assets was only slightly above the 11.5 percent regulatory floor, leaving limited room for further deterioration.
The pressure continued into 2026. During the first half of the year, Bank Makramah recorded a net loss of approximately Rs4.7 billion, compared with a profit during the same period a year earlier.
Net mark-up expenses increased significantly, while non-mark-up income declined. Deposits have also been falling, while the bank continues to carry a high level of infected loans.
Fresh Equity Cannot Solve Every Operating Problem
The proposed Rs10 billion injection could provide much-needed support to Bank Makramah’s capital position.
However, fresh equity alone does not resolve the wider operational challenges facing the bank.
Additional capital can strengthen regulatory ratios, but it does not automatically improve margins, recover troubled assets, rebuild deposits or restore profitability.
For a sustainable turnaround, the bank will also need to improve its core earnings, strengthen asset quality and rebuild customer confidence.
This makes the distinction between recapitalisation and a genuine business turnaround particularly important for investors assessing Bank Makramah’s next phase.
Minority Shareholders Face Further Dilution
The proposed issuance other than a rights issue is particularly relevant for minority shareholders.
Unlike a rights issue, such an arrangement does not give existing shareholders the same first opportunity to participate in the new share issuance. Depending on the final terms, a private allotment to the existing sponsor could therefore increase ownership concentration while diluting outside investors.
Bank Makramah already has a highly concentrated ownership structure.
The latest development makes transparency around the proposed Rs10 billion transaction increasingly important for minority shareholders.
Four Questions Investors Should Be Asking
The September 10 communication leaves several questions open.
Investors will want to know why the DM Holdings-led consortium proposal ended, what valuation or price will be used for the proposed Rs10 billion conversion, when the funds will actually be received by the bank and how the State Bank of Pakistan will treat the advance before the shares are formally issued.
These details could materially affect how investors assess the transaction and its impact on Bank Makramah’s capital position.
Until greater clarity emerges, the latest development appears less like a new ownership story and more like another stage in the bank’s long-running recapitalisation effort.
Bank Makramah’s Next Move Will Matter
Bank Makramah has secured a potential source of additional sponsor capital, but the end of the consortium proposal removes the possibility of a new strategic investor for now.
The Rs10 billion plan could strengthen the bank’s balance sheet, yet investors will ultimately judge the move by whether it translates into stronger earnings, better asset quality and a more sustainable deposit base.
For minority shareholders, the terms of the proposed issuance and the explanation behind the consortium’s withdrawal will be just as important as the headline capital injection.